Magazine
Issue 1 - 2013
Letter from the Editor
Magnus Gisslén
CROI 2013 in Atlanta
Per Lundblad
Declining HIV Drug Resistance in Europe
Graeme J. Moyle
HIV Cure: Breaking News
Christine Katlama
Antiretrovirals: New and Old
José Arribas
Topical Conferences in 2013
HIV & Hepatitis News
Leo Flamholc
The (longer than expected?) Path Towards IFN-free Therapy of Hepatitis C
Heiner Wedemeyer
Issue 4 2012
In this issue:
Letter from the Editor
Magnus Gisslén
Eleventh International Congress on Drug Therapy in HIV Infection
Per Lundblad
HIV11: More on viral escape in cerebrospinal fluid, CPE score, boosted protease inhibitor monotherapy and neurocognitive impairment
José Arribas
New Treatments for HCV. Report from the AASLD Meeting in Boston November 2012
Ola Weiland
Towards an HIV Cure: The Scientific Strategy is Launched
Alain Lafeuillade
Time for Universal Testing
Graeme J. Moyle
HIV & Cancer: A Dangerous Gang
Christine Katlama
Interview with Christine Katlama
Per Lundblad
Topical Conferences in 2013
Issue 3 2012
In this Issue
Letter from the editor
Magnus Gisslén
HIV Nordic Summer Meeting
Per Lundblad
Insulin Resistance and Diabetes mellitus in HIV
Graeme J. Moyle
HIV and Aging: a new era for both patients and physicians
Christine Katlama
Oral doxycycline for syphilis and other spirochetosis in HIV-infected patients
Lars Hagberg
Report from the 19th International AIDS Conference in Washington
José Arribas
Issue 2 2012
In this issue
Letter from the editor
Magnus Gisslén
Current Guidelines for HIV Care:
Lessons learned at the 2012 International Symposium
on HIV & Emerging Infectious Diseases (ISHEID)
Alain Lafeuillade, Emilie Hope-Rapp, Assi Assi, Gilles Hittinger & Cécile Poggi
How will the new protease inhibitors be used
in the treatment of chronic hepatitis C?
Jean-Michel Pawlotsky
Protease-inhibitor monotherapy and
neurocognitive impairment: Friend or Foe?
José Arribas
Typical cerebrospinal fluid findings
in asymptomatic HIV
Magnus Gisslén & Lars Hagberg
News on HIV and Renal Function
Graeme J. Moyle
HIV primary infection: There is no reason to delay
ART in primary/recent HIV infection anymore
Christine Katlama
Topical Conferences in 2012
Issue 1 2012
In this issue
Letter from the editor
Magnus Gisslén
How to use Etravirine in clinical practice?
Christine Katlama
Report from CROI 2012 in Seattle
Per Lundblad
Rilpivirine – how should this new NNRTI
be used in the clinic?
Magnus Gisslén
Integrating HAART: The advent of QUAD
José Arribas
HIV and Inflammation
Graeme J. Moyle
Some facts and thoughts on Progressive
Multifocal Leukoencephalopathy (PML)
Paola Cinque
Topical Conferences in 2012
Issue 3 2011
In this issue
Letter from the editor
Magnus Gisslén
A step towards education and awareness
Interview with Peter Reiss
Per Lundblad
Report from the European Aids Conference/EACS
in Belgrade, Serbia
Per Lundblad
A generic future for HIV therapy?
Graeme J. Moyle
The Times They Are A-Changin’
Update from the AASLD’s Liver Meeting 2011 on
the Management of Hepatitis C Virus Infection
Martin Lagging
EACS Guidelines: Ready for the point of care
José Arribas
Dolutegravir: a next generation integrase inhibitor
Christine Katlama
Topical Conferences in 2012
Issue 2 2011
In this issue:
Letter from the editor
By Magnus Gisslén
Update on PCP
By Lars Hagberg
HIV Cure: a challenge for the millennium
By Christine Katlama
Interferon-free Directly-Acting-Antiviral (DAA)
Combination Therapies for the Treatment of HCV
Infection
By Tania M. Welzel & Stefan Zeuzem
Interview with professor Magnus Gisslén
By Per Lundblad
How my clinical practice has changed (or not) after
IAS-2010
By José Arribas
Topical Conferences in 2011/2012
Report from the first North European Workshop on
HIV Infection in the CNS (HANSA) 2011
By Urban Carlström
Abacavir and CV risk
By Graeme J. Moyle
Issue 1 2011
In this issue:
Letter from the editor
By Magnus Gisslén
What is the life expectancy of an HIV positive person and what kind of medical problems does he face?
By Niels Obel
Report from CROI in Boston 2011.
By Per Lundblad
Treatment of Hepatitis C in patients with HIV
By Martin Vogel & Jürgen K. Rockstroh
HAND in the cART era, is it a problem?
By Magnus Gisslén
4th International Meeting on HIV Infection and the Central Nervous System – Preliminary Programme
NRTI sparing strategies in antiretroviral naïve patients: the jury is still out.
By José Arribas
Management of visceral adiposity in persons with HIV Infection
By Graeme J. Moyle
To switch or not to switch? – That is the question.
By Christine Katlama
Topical Conferences in 2011
